Chapter 18: Cholinesterase Inhibitors and Their Use in Myasthenia Gravis Flashcards
Myasthenia Gravis
- autoimmune process in which antibodies attack nicotine receptors on skeletal muscles
- characterized by fluctuating muscle weakness and predisposition to rapid fatigue
Myasthenia Gravis Common Symptoms
- ptosis, dysphagia, and weakness of the skeletal muscles
Myasthenia Gravis Treatment with cholinesterase inhibitors beneficial effects
- increased muscle strength
Myasthenia Gravis Treatment with cholinesterase inhibitors side effects
- excessive muscarinic response
sings of undermedication
ptosis and difficultly swallowing
sings of overmedication
- excessive salvation
Cholinergic crisis
- characterized by extreme muscle weakness or frank paralysis and signs of excessive muscarinic stimulation
treatment for cholinergic crisis
- respitory support and atropine
Myasthenic crisis
extreme muscle weakness,
- caused by insufficient ACh at the neuromuscular junction
- inadequate medication
if a myasthenic crisis is left untreated
can result in dealth as a result of the paralysis of the muscles of respiration
what is used to relieve a myasthenic crisis
Cholinerase inhibitor
- neostigmine
Cholinesterase inhibitors
- drugs that prevent the degration of ACh by acetylcholinesterase
why do cholinesterase inhibitors have limited therapeutic uses
- lack selectivity
what are the therapeutic applications of cholinesterase inhibitors
- myasthenia gravis
- glucoma
- alzheimers disease
- parkinsons disease
- dementia
- muscarinic antagonist poisoning
Pridostigmine [Mestinon] is used for
management of myasthenia gravis